Rachel
Rachel Anunu, Haifa IL
Patent application number | Description | Published |
---|---|---|
20110287030 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION - A method of reducing an inflammatory response in a subject is provided. The method comprising providing to a subject in need thereof a therapeutically effective amount of an agent capable of reducing activity and/or expression of a scavenger receptor or of an effector thereof, thereby reducing the inflammatory response in the subject. | 11-24-2011 |
20110287457 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION - A method of reducing an inflammatory response in a subject is provided. The method comprising providing to a subject in need thereof a therapeutically effective amount of an agent capable of reducing activity and/or expression of a scavenger receptor or of an effector thereof, thereby reducing the inflammatory response in the subject. | 11-24-2011 |
20130095119 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION - A method of reducing an inflammatory response in a subject is provided. The method comprising providing to a subject in need thereof a therapeutically effective amount of an agent capable of reducing activity and/or expression of a scavenger receptor or of an effector thereof, thereby reducing the inflammatory response in the subject. | 04-18-2013 |
20130259874 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION - A method of reducing an inflammatory response in a subject is provided. The method comprising providing to a subject in need thereof a therapeutically effective amount of an agent capable of reducing activity and/or expression of a scavenger receptor or of an effector thereof, thereby reducing the inflammatory response in the subject. | 10-03-2013 |
20140161823 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION - An isolated polypeptide is provided. The polypeptide comprising an antigen recognition domain capable of specifically binding a human scavenger receptor, wherein the antigen recognition domain comprises at least three CDR amino acid sequences selected from the group consisting of SEQ ID NO: 11, 15, 19, 23, 27 and 31. Also provided are compositions which comprise the peptide and uses of same. | 06-12-2014 |
Rachel Anunu, Nesher IL
Patent application number | Description | Published |
---|---|---|
20110189198 | Compositions and Methods for Diagnosing and Treating an Inflammation - An isolated polypeptide is provided. The polypeptide comprising an antigen recognition domain capable of specifically binding a human scavenger receptor, wherein the antigen recognition domain comprises at least three CDR amino acid sequences selected from the group consisting of SEQ ID NO: 11, 15, 19, 23, 27 and 31. Also provided are compositions which comprise the peptide and uses of same. | 08-04-2011 |
Rachel Aucock, St. Felix De Villadeix FR
Patent application number | Description | Published |
---|---|---|
20090294562 | REDUNDANT TIRE AND RUBBER COMPOUND REPROCESSING - The invention provides for methods, systems, and devices for processing rubber materials including rubber from tires, tubes, shoe soles, or any other rubber containing product. Characteristics of the rubber materials, such as chemical composition and/or product manufacturer, model, and manufacture date, can be identified. Identification can be performed by personnel, can be automated, or can be a combination thereof. The characteristics of the rubber material can be used to sort the rubber product. Rubber materials suitable for a particular end product can be selected for further processing, which can include size reduction, material separation, chemical and physical processes, devulcanization, or a combination thereof. Processed rubber materials can be stored or delivered to a user or manufacturing site with product specifications. | 12-03-2009 |
20100147980 | REDUNDANT TIRE AND RUBBER COMPOUND REPROCESSING - The invention provides for methods, systems, and devices for processing rubber materials including rubber from tires, tubes, shoe soles, or any other rubber containing product. Characteristics of the rubber materials, such as chemical composition and/or product manufacturer, model, and manufacture date, can be identified. Identification can be performed by personnel, can be automated, or can be a combination thereof. The characteristics of the rubber material can be used to sort the rubber product. Rubber materials suitable for a particular end product can be selected for further processing, which can include size reduction, material separation, chemical and physical processes, devulcanization, or a combination thereof. Processed rubber materials can be stored or delivered to a user or manufacturing site with product specifications. | 06-17-2010 |
20120104124 | REDUNDANT TIRE AND RUBBER COMPOUND REPROCESSING - The invention provides for methods, systems, and devices for processing rubber materials including rubber from tires, tubes, shoe soles, or any other rubber containing product. Characteristics of the rubber materials, such as chemical composition and/or product manufacturer, model, and manufacture date, can be identified. Identification can be performed by personnel, can be automated, or can be a combination thereof. The characteristics of the rubber material can be used to sort the rubber product. Rubber materials suitable for a particular end product can be selected for further processing, which can include size reduction, material separation, chemical and physical processes, devulcanization, or a combination thereof. Processed rubber materials can be stored or delivered to a user or manufacturing site with product specifications. | 05-03-2012 |
Rachel Audo, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20110256090 | Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof - The invention relates to methods for identifying genes involved in TRAIL-induced apoptosis, to inhibitors of the expression of genes inducing resistance of cells to TRAIL-induced apoptosis and to activators of the expression of a gene sensitizing cells to TRAIL-induced apoptosis. The invention also relates to methods for sensitizing cells to TRAIL-induced apoptosis, methods for treating hyperproliferative diseases, methods for determining the responsiveness of a subject suffering from a hyperproliferative disease to TRAIL, to pharmaceutical compositions comprising products capable of sensitizing cells to TRAIL-induced apoptosis, and to methods for determining the prognosis of a subject suffering from a hyperproliferative disease. | 10-20-2011 |
Rachel Auzely, St Georges De Commiers FR
Patent application number | Description | Published |
---|---|---|
20080306023 | Derivatives of Hyaluronic Acid, Their Preparation Process and Their Uses - The present invention relates to the use of a compound having the formula (I) wherein: n represents an integer varying from 720 to 6 200, and i varies from 1 to n, R | 12-11-2008 |
Rachel Auzely-Velty, Le Gua FR
Patent application number | Description | Published |
---|---|---|
20100204177 | PROCESS FOR PREPARING THERMOSENSITIVE (POLY(ETHYLENE OXIDE) POLY(PROPYLENE OXIDE)) DERIVATES THAT CAN BE USED TO FUNCTIONALIZE CHITOSAN - The invention relates to a thermosensitive (poly(ethylene oxide) poly(propylene oxide))-acetal derivative, which can be used to functionalize chitosan, and to the process for the preparation thereof. The invention therefore also relates to a process for functionalizing chitosan by grafting this thermosensitive copolymer and optionally another thermosensitive polymer, poly(ethylene oxide). A subject of the invention is also a chitosan-(poly(ethylene oxide) poly(propylene oxide))-poly(ethylene oxide) derivative which has the advantage of being water-soluble at physiological pH. The invention therefore also relates to the aqueous compositions comprising this derivative and to the use of this composition for the manufacture of gel by heating. | 08-12-2010 |
Rachel Bar-Shavit, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090215863 | Gene Silencing of Protease Activated Receptor 1(Par1) - The present invention relates to nucleic acid molecules, vectors, compositions, and methods useful for modulating protease-activated receptor 1 gene expression via RNA interference. In particular, the instant invention features small interfering RNA (siRNA) and short hairpin RNA (shRNA) molecules and methods for modulating the expression of protease-activated receptor 1 gene. | 08-27-2009 |
20120088311 | Immuno-Detection of a Cancerous State in a Subject - The present invention is based on the finding that antibodies raised against a fragment of PAR1-released peptide may be used to detect in a bodily fluid sample from a subject a marker associated with cancer state, if said subject has cancer. Thus, the present invention provides the methods and packages for conducting one or more of the following: determining a cancerous state in a subject, the method comprises determining binding of an antibody raised against a protease-activated receptor 1 (PAR1) released peptide or a fragment derived therefrom to a marker within a fluid sample obtained from said subject, wherein binding of said antibody to said marker being indicative of a cancerous state; determining severity of a cancerous state in a subject comprising determining level of binding of an antibody raised against PAR1 released peptide or a fragment derived therefrom to a marker within a fluid sample obtained from said subject, and comparing the level of binding with the level of prior determined standards that correlate level of antibody binding to PAR1 released peptide with severity of cancerous state; and determining the effectiveness of a therapeutic treatment of a subject with an anti-cancer agent to the subject comprising determining the level of binding of an antibody raised against PAR1 released peptide or a fragment derived therefrom to a marker within a fluid sample obtained from said subject in two or more successive time points, one or more time points are during the therapeutic treatment, wherein a difference in the level being indicative of effectiveness of therapeutic treatment. | 04-12-2012 |
Rachel Bras-Goncalves, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20090214595 | Means for Obtaining Avirulent Leishmania Promastigotes, Promastigotes Obtained, and the Applications Thereof - The invention relates to an expression vector of a gene coding for an antigenic protein of | 08-27-2009 |
Rachel Brodle, Snohomish, WA US
Patent application number | Description | Published |
---|---|---|
20120094262 | CHILDREN'S DIGITAL DAY PLANNER - A hand-held personal assistance device for a child, and in particular a young child may take the form of a cell phone, a smart phone, a digital tablet or some other hand-held device preferably sized to be comfortably held and manipulated by a small child. The device may be programmed or otherwise configured to provide a visual and/or audible announcement that utilizes alarms, sounds, music or other triggers to get a child's attention at a desired time for a particular task, and thus helps the child develop a learned association with the announcement and the time for the desired task. | 04-19-2012 |
Rachel Bundang, Palmetto, FL US
Patent application number | Description | Published |
---|---|---|
20100055269 | METHOD FOR PRODUCTION OF COCONUT WATER BEVERAGE AND BLENDED JUICE BEVERAGES WITH COCONUT WATER - A method for producing a coconut water beverage having a pH below 4.5 by adding a food grade acid to coconut water. The method coverts coconut water from a low-acid food to a high-acid food which allows the coconut water to be subjected to less severe commercial sterilization processing and preserves the natural taste and aroma of the coconut water. The present invention is also directed to a blended beverage comprising coconut water and fruit juice and having natural isotonic properties. | 03-04-2010 |
Rachel Cannara, Adliswil CH
Patent application number | Description | Published |
---|---|---|
20090255462 | DEVICE FORMED BY PROBE-BASED LITHOGRAPHY UTILIZING THERMOMECHANICALLY ACTIVATED POLYMERS - Device having features formed utilizing probe-based lithography, including: depositing a preceramic polymer on a substrate; writing nanoscale features in the polymer by locally transforming the preceramic polymer via a chemical reaction causing it to undergo a permanent phase change into hardened, ceramic material, the chemical reaction activated with a prescribed activation energy supplied by heat and/or pressure applied by a probe tip; depositing new layers and continuing according to a desired three-dimensional pattern; by cross-linking unactivated preceramic polymer to act as a support medium that isolates a formed ceramic structure mechanically and/or electrically; and where the ceramic pattern is made electrically conductive by (a) incorporating dopant elements into or onto the preceramic polymer, or (b) performing the write step in a chemically-active environment that supplies dopant atoms during the chemical reaction. | 10-15-2009 |
20090256275 | THERMOMECHANICALLY-ACTIVATED TIP SHAPE AND REGISTRY RESTORATION FOR PROBE ARRAY DEVICES UTILIZING THERMOMECHANICALLY-ACTIVATED POLYMERS - A method of repairing worn or blunt probe tips, attaching a desired tip material, or defining the registry of probe tips relative to planar surface, including: pressing a probe tip or an array of probe tips into a substrate pre-patterned with an array of tip-shaped molds, the molds containing a preceramic material that can bond to the worn probe tips by thermal activation, the substrate having a protective layer that prevents the preceramic material and/or thermally-activated ceramic material from bonding to the substrate; pressing the worn probe tips into the molds while heating the worn probe tips causing the preceramic material to bond to the worn probe tips and form a solid ceramic material; forming an array comprising a plurality of reconstructed probe tips that are sharper or consisting of a different material than the original worn or base probe tips; and reading and/or writing, with the array comprising the plurality of reconstructed probe tips, data that was unreadable and/or unwritable with the original probe tips due to tip shape or lack of registry with a planar pattern. | 10-15-2009 |
20100085071 | THERMOELECTRIC DEVICE AND METHOD - A system, device and method for electrically addressing an element include providing a thermoelectric layer in proximity with an area to be addressed and positioning a probe in proximity of the thermoelectric layer. Electrical activity is induced in the thermoelectric layer by applying heat from the probe. A response is caused in the area to be addressed. | 04-08-2010 |
20100175156 | Three-Dimensional Imaging and Manipulation - A three-dimensional imaging and manipulation tool is provided. Techniques for creating a three-dimensional imaging and manipulation tool include combining high-resolution capability of a probe with three-dimensional imaging capability of a heater sensor. Also, techniques for positioning a nano-manipulation device relative to a surface are provided. The techniques include using a heater sensor for non-contact imaging, linking the heater sensor to the nano-manipulation device, and positioning the nano-manipulation relative device to a surface. | 07-08-2010 |
Rachel Caspi, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20080199460 | Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity. | 08-21-2008 |
20100111950 | USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity. | 05-06-2010 |
20100111954 | USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity. | 05-06-2010 |
20110142831 | USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity. | 06-16-2011 |
20130045943 | A3AR AGONISTS FOR THE TREATMENT OF UVEITIS - The present disclosure relates to the use of an A | 02-21-2013 |
20130323251 | USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity. | 12-05-2013 |
20140248279 | USE OF IL-23 AND IL-17 ANTIAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE - Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity. | 09-04-2014 |
Rachel Chiappa, Sainte Agnes FR
Patent application number | Description | Published |
---|---|---|
20110020124 | TIP-FORMING MEMBER FOR A WHEEL OF A HYDRAULIC MACHINE, AND WHEEL AND HYDRAULIC MACHINE EQUIPPED WITH SUCH A MEMBER - This member ( | 01-27-2011 |
Rachel Cohen, Hadera IL
Patent application number | Description | Published |
---|---|---|
20090181086 | Rasagiline formulations, their preparation and use - Disclosed are formulations which are designed to release rasagiline mesylate while maintaining specific pharmacokinetic properties. | 07-16-2009 |
20100189787 | Delayed release rasagiline citrate formulation - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 07-29-2010 |
20100189788 | Delayed release rasagiline base formulation - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 07-29-2010 |
20100189790 | Delayed release rasagiline formulation - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 07-29-2010 |
20100189791 | Delayed release rasagiline malate formulation - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 07-29-2010 |
20120003310 | DELAYED RELEASE RASAGILINE FORMULATION - Disclosed are formulations of rasagiline base which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. Also, disclosed are rasagiline citrate salt and the use and process of manufacture thereof. | 01-05-2012 |
20120100189 | DELAYED RELEASE RASAGILINE MALATE FORMULATION - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 04-26-2012 |
20120263789 | DELAYED RELEASE RASAGILINE FORMULATION - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 10-18-2012 |
20140186514 | DELAYED RELEASE RASAGILINE FORMULATION - Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties. | 07-03-2014 |
Rachel Cohen Kupiec, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20090186027 | SINGLE CHAIN ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE - Anti-AβP scFvs and single domain antibodies were generated, and when these antibodies were displayed on filamentous phage or as soluble protein molecules, stabilized by the maltose binding protein, they could prevent the fibrilization of Abp 1-40 and disaggregate Abp 1-40 fibrils generated in vitro. The anti-Aβp scFv antibodies also stained amyloid neuritic plaques on slices from transgenic mice. The anti-ABP scFv and single domain antibodies can be used for inhibiting or treating Alzheimer's disease. | 07-23-2009 |
20090317324 | FILAMENTOUS BACTERIOPHAGE DISPLAYING PROTEIN AS A BINDER OF ANTIBODIES AND IMMUNOCOMPLEXES FOR DELIVERY TO THE BRAIN - The present invention relates to a phage display vehicle composed of a filamentous bacteriophage displaying on its surface, as a non-filamentous bacteriophage molecule, protein A or a fragment or variant thereof capable of binding the Fc portion of antibodies, and an antibody or an antigen-antibody immunocomplex bound to protein A or a fragment or variant thereof by its Fc portion. The phage display vehicle is formulated into a pharmaceutical composition and can be used to treat/inhibit or to diagnose a brain disease, disorder or condition. | 12-24-2009 |
20120114650 | SINGLE CHAIN ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE - Anti-AβP scFvs and single domain antibodies were generated, and when these antibodies were displayed on filamentous phage or as soluble protein molecules, stabilized by the maltose binding protein, they could prevent the fibrilization of Aβp 1-40 and disaggregate Aβp 1-40 fibrils generated in vitro. The anti-Aβp scFv antibodies also stained amyloid neuritic plaques on slices from transgenic mice. The anti-AβP scFv and single domain antibodies can be used for inhibiting or treating Alzheimer's disease. | 05-10-2012 |
Rachel Cotaya, Paris FR
Patent application number | Description | Published |
---|---|---|
20080250513 | LACTOBACILLUS N-DEOXYRIBOSYL TRANSFERASES, CORRESPONDING NUCLEOTIDE SEQUENCES AND THEIR USES - The invention concerns novel polypeptides and their fragments, isolated from | 10-09-2008 |
20100015685 | LACTOBACILLUS N-DEOXYRIBOSYL TRANSFERASES, CORRESPONDING NUCLEOTIDE SEQUENCES AND THEIR USES - The invention concerns novel polypeptides and their fragments, isolated from | 01-21-2010 |
Rachel De Las Heras, Queensland AU
Patent application number | Description | Published |
---|---|---|
20100291543 | HOMOGENEOUS IN VITRO FEC ASSAYS AND COMPONENTS - Reporter fragments, reporter components, and systems adapted to detect analytes in homogeneous in vitro assays are provided, such assays employing these systems, and methods of making and using same. Particular embodiments include isolated and purified reporter fragments displaying enhanced solubility, reduced aggregation, resistance to inhibitors, and enhanced suitability for use in homogeneous in vitro assays. | 11-18-2010 |
Rachel Desmidt, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20080264965 | Sheet Product Dispenser - A sheet product dispenser includes a housing adapted to house sheet products therein, the housing having an arching wall, a first planar wall disposed in contact with the arching wall, and a second planar wall disposed in contact with the arching wall and the first planar wall; an opening disposed in the first planar wall or the second planar wall, the opening having a size sufficient to allow dispensing of the sheet products there-through; and an access panel forming a portion of the arching wall. | 10-30-2008 |
Rachel Desmidt, Monona, WI US
Patent application number | Description | Published |
---|---|---|
20080211189 | MULTIPURPOSE BOWL - A multipurpose bowl assembly including a bowl, a target having a coupler configured to attach the target to the bowl and a launching device coupled to the bowl and configured to propel at least one item in a direction generally toward the target. | 09-04-2008 |
Rachel Dreilinger, Lake Oswego, OR US
Patent application number | Description | Published |
---|---|---|
20120130467 | INTERFACIAL STENT AND METHOD OF MAINTAINING PATENCY OF SURGICAL FENESTRATIONS - A method according to one embodiment for maintaining patency of an opening inside the human body comprises introducing a radially self-expanding hollow stent into the opening while the stent is retained in a radially compressed state, wherein the stent has enlarged ends and a reduced intermediate portion. The stent is introduced into the opening such that its intermediate portion extends through the opening and the enlarged ends are positioned outside of the opening. Once deployed, at least the end portions of the stent expand on opposing faces of the opening to resist dislodgement of the stent from the opening. The stent is preferably biodegradable, such that it is eliminated from the surgical site over a period of weeks to months, by which time the patency of the opening is more assured. The method can be used in combination with, for example, an endoscopic surgical method such as endoscopic third ventriculostomy for treating hydrocephalus of a brain. | 05-24-2012 |
20120232554 | Alignment Plate for Lower-extremity Ring Fixation, Method of Use, and System - An alignment plate having a viewing window and three adjustable strut members enables a surgeon to better place external fixation pins and an external fixation ring system relative to a desired anatomical feature of the lower extremity. | 09-13-2012 |
20150080914 | BIOABSORBABLE CLIPS AND APPLICATOR FOR TISSUE CLOSURE - Surgical clips and surgical applicators used in performing rapid tissue closure in either minimally invasive surgeries or traditional open procedures are provided. In one example approach, a surgical clip comprises opposing sides extending from a top portion and terminating at tips positioned below the top portion. The resting position of the clip is its closed position, and in the closed position, the tips are set at a first distance apart. Each side has a cut-out (or hole or aperture) opposite one another. Each cut-out is fully surrounded by the side and does not extend to the top or tips. Each cut-out is configured to engage an inwardly turned hook at the end of a clip array or clip applicator such that the sides bend outwardly away from each other when pressure is applied on the top portion of the clip, thereby placing the clip in an open position. | 03-19-2015 |
Rachel Eachus, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100218283 | POLYNUCLEOTIDES ENCODING ISOPRENOID MODIFYING ENZYMES AND METHODS OF USE THEREOF - The present invention provides isolated nucleic acids comprising nucleotide sequences encoding isoprenoid modifying enzymes, as well as recombinant vectors comprising the nucleic acids. The present invention further provides genetically modified host cells comprising a subject nucleic acid or recombinant vector. The present invention further provides a transgenic plant comprising a subject nucleic acid. The present invention further provides methods of producing an isoprenoid compound, the method generally involving culturing a subject genetically modified host cell under conditions that permit synthesis of an isoprenoid compound modifying enzyme encoded by a subject nucleic acid. | 08-26-2010 |
Rachel Ebner, Raanana IL
Patent application number | Description | Published |
---|---|---|
20110162059 | APPARATUS AND METHOD FOR SECURE REMOTE PROCESSING - A method and apparatus for providing on-demand services to an organization. The services are provided by a hosting center. The apparatus comprises an on-premises connectivity agent at the organization, which receives requests or commands from computing platforms within the organization and concentrates all communication to and from the hosting center. The on-premises connectivity agent embeds or otherwise introduces organization metadata to the messages. The apparatus further comprises a hosted connectivity agent associated with the hosting center. The apparatus may further comprise a central connectivity component for routing communication between the on-premises connectivity agent and the hosted connectivity agent, in accordance with the metadata. Communication between the on-premises connectivity agent and the central connectivity component flows through a secure channel and comprises only communications related to the organization. Communication between the central connectivity component and the hosted connectivity agent may comprise communications related multiple organizations. Such communications may be multiplexed. | 06-30-2011 |
20110162074 | APPARATUS AND METHOD FOR REMOTE PROCESSING WHILE SECURING CLASSIFIED DATA - A method and apparatus for providing an on-demand service to an organization by a hosting center, without having classified data leave the organization network, comprising: receiving a message sent from a first computing platform of the organization to an on-premise connectivity agent, the message comprising classified data; generating a code in accordance with the classified data, by a credential hiding component associated with the on-premise connectivity agent; sending the code to the hosting center; receiving a second message from the hosting center, the second message comprising the code; retrieving the classified data using the code by a credential retrieval component associated with the on-premise connectivity agent; and sending a third message to a second computing platform, the third message comprising the classified data. | 06-30-2011 |
20130311877 | Automatic Retrieval of Themes and Other Digital Assets from an Organizational Website - The present disclosure involves systems, software, and computer implemented methods for determining one or more themes for a portal site. One example process includes operations for identifying a reference to an organizational site that is to be used as a thematic basis for a new portal site. The reference is used to identify a representation of the organizational site. The representation is analyzed based on an analysis rule set. At least one potential theme associated with the organizational site is determined, based on the analysis, and the at least one potential theme is presented to a user. | 11-21-2013 |
20140040177 | RUNTIME ADAPTATION IN DYNAMIC WORKSPACES - The disclosure generally describes computer-implemented methods, software, and systems for search-, context-, and rule-based creation and runtime adaptation in dynamic workspaces. One computer-implemented method includes receiving an access request for an enterprise workspace from a requestor, determining properties of the requestor, determining at least one rule associated with the requestor, determining a context of the determined requestor, generating, by operation of at least one computer, the requested enterprise workspace, and modifying the generated enterprise workspace by executing the determined at least one rule for the determined context. | 02-06-2014 |
20140123020 | MULTIPLE USER INTERFACE PLATFORM SUPPORT FOR PORTAL APPLICATIONS - The disclosure generally describes methods, media, and systems for providing multiple user interface platform technology support for portal applications. One computer-implemented method includes receiving, using a user-interface (UI) framework of a computing system including one or more computers, a request for incremental data from a specified application of at least one application, wherein, prior to receipt of the request, UI platform code formatted according to a particular UI platform technology type was transmitted to a requestor of the request, parsing the request to determine at least the specified application, determining whether the specified application includes a UI platform handler, determining a responsive UI platform technology type, and determining whether to switch the particular UI platform technology type to the responsive UI platform technology type. | 05-01-2014 |
20140222914 | SYNCHRONIZING USER RELATIONSHIP ACROSS COMPUTER SYSTEMS IMPLEMENTING WORKSPACES - Computer-implemented methods, computer software, and computer systems for synchronizing user relationship across computer systems implementing workspaces. A computer system that provides features accessible by users by executing a workspace is accessed. Features provided to the users by remaining computer systems depends on the relationships between the users. A triggering event that represents a change to the computer workspace—for example, addition or removal or a user in the workspace, addition or removal of content in the workspace—is detected. Features provided to a first user by the remaining computer systems is affected by the change. Changes in relationships between the first user and the remaining users responsive to the change are determined, and provided to one or more of the remaining computer systems as respective messages that include the changes in the relationships. | 08-07-2014 |
20140282024 | PROVIDING MULTIPLE ROLES IN COMPUTER-IMPLEMENTED WORKSPACES - Providing multiple roles in computer-implemented workspaces. When a first computer workspace in which a user has been assigned a first role and a second role is accessed, a first subset of content defined by the first role and a second subset of content defined by the second role can be made accessible to the user. Input to switch access from the first computer workspace to a second computer workspace that is different from the first computer workspace and in which the user is assigned only the second role can be received. In response, only the second subset of content can be provided to the user and access to the first subset of content can be prohibited. | 09-18-2014 |
20150088897 | AUTOMATIC REMOVAL OF INAPPROPRIATE CONTENT - The disclosure generally describes computer-implemented methods, software, and systems for automatically removing inappropriate content. One example method includes: identifying a report of inappropriate content received from a user, the report identifying a content item the user has identified as inappropriate and an identification of the user, determining whether to automatically remove the content item based at least in part on the identity of the user, and removing the content item upon determining that the content should be removed. In some instances, the user is associated with a report weight. The report weight can be based, at least in part, on a business role of the user. Determining whether to automatically remove the content item may include determining that the user or a business role of the user is associated with an automatic removal rule, and removing the content item upon determining that the report is associated the user. | 03-26-2015 |
Rachel Glim, New York, NY US
Patent application number | Description | Published |
---|---|---|
20100274701 | METHOD AND APPARATUS FOR PROVIDING PRE-EXISTING CUSTOMERS AND PROSPECTIVE CUSTOMERS WITH AN IMMEDIATELY ACCESSIBLE ACCOUNT - A system and method for providing in real-time an immediately accessible customized transaction account via the internet is disclosed. In particular, the system and method recognizes distinct access codes which are correlated to the credit profile of a person accessing an on-line application system via a computer network. During operation of the invention, a party may be driven to the on-line application system via the internet to conduct a transaction in response to an invitation to enroll in a special program. Upon entering the on-line application system, the accessing party may be unilaterally given the opportunity to apply for a special offer, which has been tailored to the accessing party's credit profile. | 10-28-2010 |
20110166923 | METHOD AND APPARATUS FOR PROVIDING PRE-EXISTING AND PROSPECTIVE CUSTOMERS WITH AN IMMEDIATELY ACCESSIBLE ACCOUNT - A system and method for providing in real-time an immediately accessible customized transaction account via the internet is disclosed. In particular, the system and method recognizes distinct access codes which are correlated to the credit profile of a person accessing an on-line application system via a computer network. During operation of the invention, a party may be driven to the on-line application system via the internet to conduct a transaction in response to an invitation to enroll in a special program. Upon entering the on-line application system, the accessing party may be unilaterally given the opportunity to apply for a special offer, which has been tailored to the accessing party's credit profile. | 07-07-2011 |
Rachel Hakim, Kibbutz Ramat Hakovesh IL
Patent application number | Description | Published |
---|---|---|
20110003337 | IMMUNOGLOBULIN COMPOSITIONS AND METHODS OF PRODUCING SAME - 1. A method of producing an immunoglobulin in a bacterial culture, the method comprising: | 01-06-2011 |
Rachel Karchin, Towson, MD US
Patent application number | Description | Published |
---|---|---|
20110229479 | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA - We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as in glioblastomas that develop from these lower grade lesions. Those tumors without mutations in IDH1 often had mutations at the analogous R172 residue of the closely related IDH2 gene. These findings have important implications for the pathogenesis and diagnosis of malignant gliomas. | 09-22-2011 |
20120115735 | Pathways Underlying Pancreatic Tumorigenesis and an Hereditary Pancreatic Cancer Gene - There are currently few therapeutic options for patients with pancreatic cancers and new insights into the pathogenesis of this lethal disease are urgently needed. To this end, we performed a comprehensive analysis of the genes altered in 24 pancreatic tumors. First, we determined the sequences of 23,781 transcripts, representing 20,583 protein-encoding genes, in DNA from these tumors. Second, we searched for homozygous deletions and amplifications using microarrays querying ˜one million single nucleotide polymorphisms in each sample. Third, we analyzed the transcriptomes of the same samples using SAGE and next-generation sequencing-by-synthesis technologies. We found that pancreatic cancers contain an average of 63 genetic alterations, of which 49 are point mutations, 8 are homozygous deletions, and 6 are amplifications. Further analyses revealed a core set of 12 regulatory processes or pathways that were each genetically altered in 70% to 100% of the samples. The data suggest that dysregulation of this core set of pathways is responsible for the major features of pancreatic tumorigenesis. | 05-10-2012 |
20120202207 | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA - We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as in glioblastomas that develop from these lower grade lesions. Those tumors without mutations in IDH1 often had mutations at the analogous R172 residue of the closely related IDH2 gene. These findings have important implications for the pathogenesis and diagnosis of malignant gliomas. | 08-09-2012 |
20140187764 | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA - We found mutations of the R132 residue of isocitrate dehydrogenase 1 (IDH1) in the majority of grade II and III astrocytomas and oligodendrogliomas as well as in glioblastomas that develop from these lower grade lesions. Those tumors without mutations in IDH1 often had mutations at the analogous R172 residue of the closely related IDH2 gene. These findings have important implications for the pathogenesis and diagnosis of malignant gliomas. | 07-03-2014 |
20150025861 | GENETIC SCREENING COMPUTING SYSTEMS AND METHODS - Various techniques are disclosed that allow phenotype-related data to be aggregated from any number of online sources. A statistical model may be generated using the aggregated data that, based on (epi)genome, microbiome, or other omics information regarding a subject, predicts the probability of the subject having the phenotype. | 01-22-2015 |
Rachel Kasinskas, Amesbury, MA US
Patent application number | Description | Published |
---|---|---|
20120156728 | CLONAL AMPLIFICATION OF NUCLEIC ACID ON SOLID SURFACE WITH TEMPLATE WALKING - Novel methods of generating a localized population of immobilized clonal amplicons on a support are provided. | 06-21-2012 |
20130203607 | METHODS, COMPOSITIONS, SYSTEMS, APPARATUSES AND KITS FOR NUCLEIC ACID AMPLIFICATION - In some embodiments, the present teachings provide methods for paired end sequencing. In some embodiment, a polynucleotide template to be subjected to paired end sequencing comprises at least one cross linking moiety and at least one scissile moiety. In some embodiments, a paired end sequencing reaction comprises (a) a forward sequencing step, (b) a cleavage step, and (c) a reverse sequencing step. In some embodiments, a paired end sequencing reaction comprises (a) a forward sequencing step, (b) a cross-linking step, (c) a cleavage step, and (d) a reverse sequencing step. | 08-08-2013 |
20130225421 | NUCLEIC ACID AMPLIFICATION - In some embodiments, the present teachings provide methods for nucleic acid amplification, comprising forming a reaction mixture, and subjecting the reaction mixture to conditions suitable for nucleic acid amplification. In some embodiments, methods for nucleic acid amplification include subjecting the nucleic acid to be amplified to partially denaturing conditions. In some embodiments, methods for nucleic acid amplification include amplifying without fully denaturing the nucleic acid that is amplified. In some embodiments, the methods for nucleic acid amplification employ an enzyme that catalyzes homologous recombination and a polymerase. In some embodiments, methods for nucleic acid amplification can be conducted in a single reaction vessel. In some embodiments, methods for nucleic acid amplification can be conducted in a single continuous liquid phase of a reaction mixture, without need for compartmentalization of the reaction mixture or immobilization of reaction components. In some embodiments, methods for nucleic acid amplification comprise a amplifying at least one polynucleotide onto a surface under isothermal amplification conditions, optionally in the presence of a polymer. The polymer can include a sieving agent and/or a diffusion-reducing agent. | 08-29-2013 |
20130281307 | NUCLEIC ACID AMPLIFICATION - In some embodiments, the present teachings provide methods for nucleic acid amplification, comprising forming a reaction mixture, and subjecting the reaction mixture to conditions suitable for nucleic acid amplification. In some embodiments, methods for nucleic acid amplification include subjecting the nucleic acid to be amplified to partially denaturing conditions. In some embodiments, methods for nucleic acid amplification include amplifying without fully denaturing the nucleic acid that is amplified. In some embodiments, the methods for nucleic acid amplification employ an enzyme that catalyzes homologous recombination and a polymerase. In some embodiments, methods for nucleic acid amplification can be conducted in a single reaction vessel. In some embodiments, methods for nucleic acid amplification can be conducted in a single continuous liquid phase of a reaction mixture, without need for compartmentalization of the reaction mixture or immobilization of reaction components. In some embodiments, methods for nucleic acid amplification comprise a amplifying at least one polynucleotide onto a surface under isothermal amplification conditions, optionally in the presence of a polymer. The polymer can include a sieving agent and/or a diffusion-reducing agent. | 10-24-2013 |
20140024040 | METHODS AND KITS FOR BREAKING EMULSIONS - The disclosure relates generally to methods, systems, compositions and kits for breaking a water-in-oil emulsion including one or more biomolecules dispersed in an aqueous phase of the water-in-oil emulsion. In some embodiments, the disclosure relates to obtaining a first emulsion including a continuous hydrophobic fraction and a discontinuous aqueous fraction, the aqueous fraction having one or more biomolecules dispersed therein, breaking the first emulsion by contacting the first emulsion with a breaking solution including a second emulsion, where the second emulsion includes a discontinuous phase of organic extraction solvent dispersed in a continuous aqueous phase, and centrifuging to separate the phases of the resulting mixture. In some embodiments, the disclosure relates generally to methods, kits and systems for extracting biomolecules from a water-in-oil emulsion, including breaking a water-in-oil emulsion comprising a plurality of aqueous droplets in a continuous hydrophobic fraction using a breaking solution to produce a resulting reaction mixture containing one or more biomolecules and manipulating the resulting reaction mixture to form at least two phases, where one of the phases includes an aqueous phase containing the one or more biomolecules. | 01-23-2014 |
20140080717 | NUCLEIC ACID AMPLIFICATION - In some embodiments, the present teachings provide methods for nucleic acid amplification, comprising forming a reaction mixture, and subjecting the reaction mixture to conditions suitable for nucleic acid amplification. In some embodiments, methods for nucleic acid amplification include subjecting the nucleic acid to be amplified to partially denaturing conditions. In some embodiments, methods for nucleic acid amplification include amplifying without fully denaturing the nucleic acid that is amplified. In some embodiments, the methods for nucleic acid amplification employ an enzyme that catalyzes homologous recombination and a polymerase. In some embodiments, methods for nucleic acid amplification can be conducted in a single reaction vessel. In some embodiments, methods for nucleic acid amplification can be conducted in a single continuous liquid phase of a reaction mixture, without need for compartmentalization of the reaction mixture or immobilization of reaction components. In some embodiments, methods for nucleic acid amplification comprise a amplifying at least one polynucleotide onto a surface under isothermal amplification conditions, optionally in the presence of a polymer. The polymer can include a sieving agent and/or a diffusion-reducing agent. | 03-20-2014 |
20140147852 | NUCLEIC ACID AMPLIFICATION - In some embodiments, the present teachings provide methods for nucleic acid amplification, comprising forming a reaction mixture, and subjecting the reaction mixture to conditions suitable for nucleic acid amplification. In some embodiments, methods for nucleic acid amplification include subjecting the nucleic acid to be amplified to partially denaturing conditions. In some embodiments, methods for nucleic acid amplification include amplifying without fully denaturing the nucleic acid that is amplified. In some embodiments, the methods for nucleic acid amplification employ an enzyme that catalyzes homologous recombination and a polymerase. In some embodiments, methods for nucleic acid amplification can be conducted in a single reaction vessel. In some embodiments, methods for nucleic acid amplification can be conducted in a single continuous liquid phase of a reaction mixture, without need for compartmentalization of the reaction mixture or immobilization of reaction components. In some embodiments, methods for nucleic acid amplification comprise a amplifying at least one polynucleotide onto a surface under isothermal amplification conditions, optionally in the presence of a polymer. The polymer can include a sieving agent and/or a diffusion-reducing agent. | 05-29-2014 |
20140148345 | NUCLEIC ACID AMPLIFICATION - In some embodiments, the present teachings provide methods for nucleic acid amplification, comprising forming a reaction mixture, and subjecting the reaction mixture to conditions suitable for nucleic acid amplification. In some embodiments, methods for nucleic acid amplification include subjecting the nucleic acid to be amplified to partially denaturing conditions. In some embodiments, methods for nucleic acid amplification include amplifying without fully denaturing the nucleic acid that is amplified. In some embodiments, the methods for nucleic acid amplification employ an enzyme that catalyzes homologous recombination and a polymerase. In some embodiments, methods for nucleic acid amplification can be conducted in a single reaction vessel. In some embodiments, methods for nucleic acid amplification can be conducted in a single continuous liquid phase of a reaction mixture, without need for compartmentalization of the reaction mixture or immobilization of reaction components. In some embodiments, methods for nucleic acid amplification comprise a amplifying at least one polynucleotide onto a surface under isothermal amplification conditions, optionally in the presence of a polymer. The polymer can include a sieving agent and/or a diffusion-reducing agent. | 05-29-2014 |
Rachel Katz-Brull, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20080287774 | Magnetic Resonance Imaging and Spectroscopy Means and Methods Thereof - The present invention discloses neurochemical agents and biochemical agents for human or mammalian neuro- and body-metabolic imaging, comprising chemicals involved in neuronal or glial function, neuromodulatory processes in the brain of said human or mammalian, vascular function, or organ specific metabolic processes; said neurochemical and biochemical agents are labeled with stable isotopes selected from a group including carbon-13, nitrogen-15, deuterium, fluorine-19 or a combination thereof in predetermined positions, so as to enhance the detectability of the agents and their metabolic successors. | 11-20-2008 |
Rachel Katz-Brull, Modi'In-Maccabim-Re'Ut IL
Patent application number | Description | Published |
---|---|---|
20110262346 | REACTORS AND METHODS FOR PRODUCING SPIN ENRICHED HYDROGEN GAS - The present invention provides a reactor and a process for producing spin enriched hydrogen and/or deuterium gas. | 10-27-2011 |
20120156139 | ISOTOPICALLY LABELED NEUROCHEMICAL AGENTS AND USES THEROF FOR DIAGNOSING CONDITIONS AND DISORDERS - The invention relates to a neurochemical agent comprising at least one isotopically labeled carbon atom directly bonded to at least one deuterium atom, uses thereof for the manufacture of a composition for diagnosing and evaluating a condition or disease and kits comprising said agent. The invention further encompasses methods for diagnosing and evaluating a condition or disease in a subject utilizing a composition of the invention. | 06-21-2012 |
20130230468 | ISOTOPICALLY LABELED DEOXY-GLUCOSE AND DERIVATIVES THEREOF, COMPOSITIONS COMPRISING THEM AND USES THEREOF - The present invention provides isotopically labeled deoxy-glucose and derivatives thereof, methods of their preparation, ration, kits comprising them and uses thereof for spin hyperpolarized magnetic resonance imaging, utilized in the quantitative and qualitative diagnosis of states, conditions, diseases, or disorders in the body of a subject. | 09-05-2013 |
20140099262 | ISOTOPICALLY LABELED CDP-CHOLINE AND USES THEREOF - The present invention provides CDP-Choline (Citicoline) and any salt thereof comprising at least one isotopically labeled carbon atom directly bonded to at least one deuterium atom, a composition comprising said CDP-Choline, uses thereof, methods for diagnosing and evaluating a state, condition, or disease in a subject utilizing CDP-Choline of the invention and kits comprising CDP-Choline of the invention. | 04-10-2014 |
Rachel Kohli Steck, Basel CH
Patent application number | Description | Published |
---|---|---|
20090136768 | Hydroxyphenyltriazines With An Aromatic Carbocyclic Fused Ring System - The instant invention relates to novel hydroxyphenyl triazine UV-absorbers with an aromatic carbocyclic fused ring system having a long wavelength shifted absorption spectrum with significant absorbance up to 420 nm. Further aspects of the invention are a process for their preparation, a UV stabilized composition containing the new UV-absorbers, a process for the stabilization of organic materials and the use of the new compounds as UV-light stabilizers for organic materials. | 05-28-2009 |
20100178512 | CHANGING SURFACE PROPERTIES BY FUNCTIONALIZED NANOPARTICLES - A process for modifying the surface of an inorganic or organic substrate with strongly adherent nanoparticles is described, providing to the surface modified substrate durable effects like hydrophobicity, hydrophilicity, electrical conductivity, magnetic properties, flame retardance, color, adhesion, roughness, scratch resistance, UV-absorbance, antimicrobial properties, antifouling properties, antiprotein properties, antistatic properties, antifog properties, release properties. In this process, an optional first step a) a low-temperature plasma, ozonization, high energy irradiation, corona discharge or a flame is caused to act on the inorganic or organic substrate, and in a second step b) one or more defined nanoparticles or mixtures of defined nanoparticles with monomers, containing at least one ethylenically unsaturated group, or solutions, suspensions or emulsions of the afore-mentioned substances, are applied, preferably at normal pressure, to the inorganic or organic substrate. In a third step c) suitable methods are applied to dry or cure those afore-mentioned substances and, optionally, in a fourth step d) a further coating is applied on the substrate so pretreated. | 07-15-2010 |
20100234485 | PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS - The present invention provides organometallic latent catalyst compounds, which are suitable as catalysts in polyaddition or polycondensation reactions which are catalysed by a Lewis acid type catalyst, in particular for the crosslinking of a blocked or unblocked isocyanate or isothiocyanate component with a polyol or polythiolto form a polyurethane (PU). | 09-16-2010 |
20120220685 | PHOTO-LATENT TITANIUM CATALYSTS - The present invention provides a photolatent Ti-chelate catalyst formulation, comprising (i) at least one compound of the formula (I) wherein R | 08-30-2012 |
20120259033 | PHOTO-LATENT TITANIUM-CHELATE CATALYSTS - The present invention provides photolatent Ti-chelate catalyst compounds of formula (I), wherein R | 10-11-2012 |
20140018461 | PHOTO-LATENT TITANIUM-OXO-CHELATE CATALYSTS - A titanium-oxo-chelate catalyst formulation, comprising: (i) at least one compound of the formula (I), wherein R | 01-16-2014 |
Rachel Krieb, Wood River, IL US
Patent application number | Description | Published |
---|---|---|
20110003299 | Canola Event PV-BNGT04(RT73) and Compositions and Methods for Detection Thereof - The present invention provides assays for detecting the presence of the PV-BNGT04(RT73) canola event based on the DNA sequence of the recombinant construct inserted into the canola genome and of genomic sequences flanking the insertion site. | 01-06-2011 |
20110258717 | CANOLA EVENT PV-BNGT04(RT73) AND COMPOSITIONS AND METHODS FOR DETECTION THEREOF - The present invention provides assays for detecting the presence of the PV-BNGT04(RT73) canola event based on the DNA sequence of the recombinant construct inserted into the canola genome and of genomic sequences flanking the insertion site. | 10-20-2011 |
Rachel Labell, Coatesville, PA US
Patent application number | Description | Published |
---|---|---|
20090112150 | CAVITATION ENHANCED TREATMENT THROUGH LOCAL DELIVERY - A method is disclosed to administer to a patient in need thereof a therapeutically effective amount of one or more therapeutic agents. The method provides a patient comprising a blood vessel, supplies a therapeutic agent comprising a plurality of gas-filled microspheres, and supplies a catheter comprising a proximal end, a distal end, and an infusion length disposed adjacent the distal end, where that infusion length is formed to include an infusion pattern comprising a plurality of apertures extending therethrough. The method catheterizes the blood vessel using the catheter, prepares an aqueous mixture comprising the first therapeutic agent, disposes that aqueous mixture in a container, interconnects the container to the proximal end of said catheter, and administers the aqueous mixture into the blood vessel through the plurality of apertures extending through the catheter. | 04-30-2009 |
Rachel Labell, Vail, AZ US
Patent application number | Description | Published |
---|---|---|
20080200862 | Method To Administer Stem Cells In Combination With One Or More Acoustically Active Materials And Ultrasound Energy - The invention comprises a method to administer stem cells to a patient in need thereof. The method provides acoustically active material, stem cells, and an ultrasound energy emitting device. The method administers the acoustically active material to the patient, administers the stem cells to the patient, and administers ultrasound energy to the patient using the ultrasound emitting device. | 08-21-2008 |
Rachel Langland, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20100173294 | DIAGNOSTIC TEST FOR SUSCEPTIBILITY TO B-RAF KINASE INHIBITORS - The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor | 07-08-2010 |
20110212991 | Diagnostic Test for Susceptibility to B-RAF Kinase Inhibitors - The present invention provides methods and reagents for the detection of a mutation in BRAF and methods of selecting, patients for treatment if a B-Raf kinase inhibitor, such as a selective B-Raf kinase inhibitor. | 09-01-2011 |
Rachel Lavaure, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20110094801 | CORING APPARATUS AND METHODS TO USE THE SAME - Example coring apparatus and methods to use the same are disclosed. A disclosed example apparatus includes a housing that is selectively pivotable in a downhole tool, a rotatable coring bit, a gear drive rotatively coupled to the housing, a key member configured to engage an inner surface of the gear drive and an outer surface of the coring bit and configured to maintain a rotational relationship between the coring bit and the gear drive, a pinion rotatively coupled to the housing, the pinion configured to engage an outer surface of the gear drive, and a motor affixed to the housing and operatively coupled to the pinion, wherein the gear drive, the key member, the pinion and the motor are configured to pivot in unison with the housing. | 04-28-2011 |
20120000711 | Coring Apparatus And Methods To Use The Same - An apparatus for conveyance via wireline or drillstring in a wellbore extending into a subterranean formation, the apparatus comprising a coring bit assembly, a first motor operatively coupled to the coring bit assembly via a gear box to rotationally drive the coring bit assembly, and a second motor to drive the coring bit assembly into the formation while the coring bit assembly is rotated by the first motor, wherein the coring bit assembly comprises a feature to permit the coring bit assembly to be broken when the coring bit assembly becomes stuck in the formation. | 01-05-2012 |
Rachel Leichte, Glen Rock, NJ US
Patent application number | Description | Published |
---|---|---|
20120128835 | RECLOSABLE FLEXIBLE PACKAGING AND METHODS FOR MANUFACTURING SAME - Flexible film packages having a partial, initial seal against ambient atmosphere and are easily openable and reclosable. The flexible film packages are generally resealable to extend the shelf-life or freshness of products contained therein once the package is initially opened. By one approach, the flexible film has two opposing edge portions that meet to form a longitudinal seal extending from a first end seal to a second end seal. The flexible film may have a score that defines a package opening. An elongated closure layer may extend over the score and may extend from a first end seal to a second end seal and within the opposing edge portions that form the longitudinal seal. The elongated closure layer may have a tack-free gripping portion used to release at least a portion of the elongated closure from the flexible film to form the package opening. | 05-24-2012 |
Rachel Leizman, Pepper Pike, OH US
Patent application number | Description | Published |
---|---|---|
20090298620 | SHOOTING SKILL AMUSEMENT DEVICE - A basketball amusement device comprises a backboard, a basket, and a self-propelled carriage. The backboard has a surface and the basket is attached to the surface of the backboard. The basket is adapted to receive a tossed ball. A support connects the backboard to the carriage. The self-propelled carriage includes a drive mechanism configured to move the carriage and backboard. The amusement device moves a predetermined distance across an associated support surface in response to the ball being received in the basket. | 12-03-2009 |
Rachel Lev-Ran, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20090213414 | Printers and Printing - A printer control system ( | 08-27-2009 |
Rachel Lobourdette, Quebec City CA
Patent application number | Description | Published |
---|---|---|
20090208948 | DETECTION OF TOXIGENIC STRAINS OF CLOSTRIDIUM DIFFICILE - Primers and probes for detection of toxin-producing (toxigenic) strains of | 08-20-2009 |
Rachel Matthai, Hoboken, NJ US
Patent application number | Description | Published |
---|---|---|
20090114494 | Collapsible Expanding Luggage - A collapsible piece of luggage is disclosed. The piece of luggage may have wheels and an extendable and retractable handle. The sidewall, bottom and cover of the luggage have sufficient rigidity to hold their own shape and may be folded into a storage configuration in which the piece of luggage is smaller in width and depth. Additionally, the luggage includes an expansion feature that allows the luggage cover to expand outward pyramidally so as to increase the storage volume of the luggage. | 05-07-2009 |
20090120752 | Collapsible Expanding Luggage - A collapsible piece of luggage is disclosed. The piece of luggage may have wheels and an extendable and retractable handle. The sidewall, bottom and cover of the luggage have sufficient rigidity to hold their own shape and may be folded into a storage configuration in which the piece of luggage is smaller in width and depth. Additionally, the luggage includes an expansion feature that allows the luggage cover to expand outward pyramidally so as to increase the storage volume of the luggage. | 05-14-2009 |
Rachel Michelin, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20090019812 | Anchoring Apparatus and Method - An anchoring apparatus that is suitable for use in anchoring a first member (such as but not limited to a façade material) ( | 01-22-2009 |
Rachel Mosckovitz-Silversmith, Rishon Le Zion IL
Patent application number | Description | Published |
---|---|---|
20100168233 | TERBINAFINE FORMULATION - The present invention provides a pharmaceutical composition comprising as the active agent a terbinafine compound, water, and at least one water-soluble or water-miscible nonionic surfactant, wherein the terbinafine compound has at least one form selected from the group consisting of free base form, acid addition salt form, ionic form, and combinations thereof; and wherein substantially no alcohol is present. | 07-01-2010 |
Rachel Nakash-Ozeri, Moshav Gimzo-Doar-Na Merkaz IL
Patent application number | Description | Published |
---|---|---|
20110166297 | MOLECULARLY IMPRINTED SMART POLYMERS (MISPs) - Molecularly imprinted smart polymers (MISPs) are provided herein, as well as novel monomers for preparing MISPs, and processes for preparing MISPs. The MISPs can be used applications such as, for example, detecting/absorbing or isolating biological and non-biological agents. The MISPs described herein comprise responsive monomeric units which undergo a physico-chemical change (e.g., a bond formation or cleavage) in response to an external change, such that the MISP selectively binds to a target molecule and releases a bound target molecule in response to the external change. | 07-07-2011 |
Rachel Nakauchi, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090094175 | INTRUSIVE SOFTWARE MANAGEMENT - Intrusion features of a landing page associated with sponsored content are identified. A feature score for the landing page based on the identified intrusion features is generated, and if the feature score for the landing page exceeds a feature threshold, the landing page is classified as a candidate landing page. A sponsor account associated with the candidate landing page can be suspended, or sponsored content associated with the candidate landing page can be suspended. | 04-09-2009 |
20090094697 | INTRUSIVE SOFTWARE MANAGEMENT - Landing pages associated with advertisements are partitioned into training landing pages and testing landing pages. Iterative training and testing of a classification mode on intrusion features of the partitioned landing pages is conducted until the occurrence of a cessation event. Feature weights are derived from the iterative training and testing, and are associated with the intrusion features. The associated feature weights and intrusion features can be used to classify other landing pages. | 04-09-2009 |
20120005753 | INTRUSIVE SOFTWARE MANAGEMENT - Intrusion features of a landing page associated with sponsored content are identified. A feature score for the landing page based on the identified intrusion features is generated, and if the feature score for the landing page exceeds a feature threshold, the landing page is classified as a candidate landing page. A sponsor account associated with the candidate landing page can be suspended, or sponsored content associated with the candidate landing page can be suspended. | 01-05-2012 |
20120311707 | INTRUSIVE SOFTWARE MANAGEMENT - Intrusion features of a landing page associated with sponsored content are identified. A feature score for the landing page based on the identified intrusion features is generated, and if the feature score for the landing page exceeds a feature threshold, the landing page is classified as a candidate landing page. A sponsor account associated with the candidate landing page can be suspended, or sponsored content associated with the candidate landing page can be suspended. | 12-06-2012 |
Rachel Nechushtai, Motza I'Llit IL
Patent application number | Description | Published |
---|---|---|
20110269939 | NEW APPROACH FOR DESIGNING DIABETES DRUGS - The present technology relates to the fields of crystallography, biochemistry, and drug design. In particular, methods and compositions for screening, identifying and designing compounds that interact with human mitoNEET. | 11-03-2011 |
Rachel Nechustai, Motza Elite IL
Patent application number | Description | Published |
---|---|---|
20100144596 | An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof - A process for obtaining a pure preparation of an apo- form of an [Fe | 06-10-2010 |
Rachel Ng, Singapore SG
Patent application number | Description | Published |
---|---|---|
20100313405 | ELECTRICAL DISCHARGE ASSEMBLY AND METHOD FOR REPAIRING DIFFUSION COOLING PASSAGES - An electrical discharge assembly for processing a workpiece having a cooling passage with first and second portions includes a first electrode having a first shape for machining the first portion of the cooling passage and a second electrode having a second shape for machining the second portion of the cooling passage. In a method for repairing cooling passages in a workpiece, a first electrode having a first shape is positioned in a cooling passage. The first electrode is electrically powered to machine a first portion of the cooling passage. A second electrode having a second shape is positioned in the cooling passage. The second electrode is electrically powered to machine a second portion of the cooling passage. | 12-16-2010 |
Rachel Ozeri, Gimzo IL
Patent application number | Description | Published |
---|---|---|
20120108631 | Sulfonamides for the Modulation of PKM2 - The invention relates to sulfonamide compounds and methods for activating PKM2. The compounds and methods are useful in treating or preventing a disease or disorder selected from cancer, cell proliferative disorder, inflammatory disorder, metabolic disorder, and immune system disorder. | 05-03-2012 |
20120302609 | Pyrazolines for the Modulation of PKM2 - The invention relates to pyrazoline substituted compounds and methods for activating PKM2. The compounds and methods are useful in treating or preventing a disease or disorder selected from cancer, cell proliferative disorder, inflammatory disorder, metabolic disorder, and immune system disorder. | 11-29-2012 |
Rachel Perkel, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20080208968 | SYSTEM AND METHOD FOR AUTOMATED DOCUMENTATION FOR SOLICITED TRADES - A system and method are provided that allow for automated documentation of all advice interactions between broker representatives on one end and clients, or prospective clients, on the other. This is accomplished by providing a computer system for storing appropriate data for each advice interaction with a client. The advice interaction data can be used to assess compliance with existing regulations, as well as for analytical and training purposes. | 08-28-2008 |
Rachel Radspinner, Newark, DE US
Patent application number | Description | Published |
---|---|---|
20110039960 | Expandable Functional TFE Copolymer Fine Powder, the Expanded Functional Products Obtained Therefrom and Reaction of the Expanded Products - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 02-17-2011 |
20120035283 | Expandable Functional TFE Copolymer Fine Powder, the Expanded Functional Products Obtained Therefrom and Reaction of the Expanded Products - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 02-09-2012 |
20130203874 | Expandable Functional TFE Copolymer Fine Powder, Expanded Products and Reacted Products Therefrom - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 08-08-2013 |
Rachel Ryznal, North Oxford, MA US
Patent application number | Description | Published |
---|---|---|
20090105201 | Pulmonary Pharmaceutical Formulations - The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment. | 04-23-2009 |
20140148424 | Pulmonary Pharmaceutical Formulations - The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment. | 05-29-2014 |
Rachel Schek, Milton, VT US
Patent application number | Description | Published |
---|---|---|
20120189584 | GENIPIN CROSS-LINKED FIBRIN GELS - The invention provides a genipin cross-linked fibrin gel. The ratio of genipin to fibrin in the gel ranges from about 0.1:1 to about 10:1 (genipin:fibrin). The gel can be hydrogel. Also provided is method for repairing tissue defects by administering the gel to site of tissue defect. | 07-26-2012 |
Rachel Shakarov, Petach-Tikva IL
Patent application number | Description | Published |
---|---|---|
20080215301 | Method and apparatus for predicting protein structure - A method of determining predicting putative contacting sites of a target protein is disclosed. The method uses a substitution matrix for calculating contact probabilities for pairs of columns in a sequence alignment containing the amino acid sequence of the target protein. The contact probabilities can also be used for predicting the three-dimensional structure of the protein. The putative contacts and/or three-dimensional structure typically correspond to the hydrophobic core of the target protein. | 09-04-2008 |
Rachel Shtekler, Shafir IL
Patent application number | Description | Published |
---|---|---|
20110160362 | FLAME-RETARDED COMPOSITIONS OF STYRENE-CONTAINING POLYMERS - A flame-retarded styrene-containing polymer composition, which comprises a styrene-containing polymer, tris(2,4,6-tribromophenoxy)-s-triazine, 0.5-1.7 wt % antimony trioxide, and an anti-dripping agent. The bromine content of the composition is generally in the range between 8 and 18 wt %. Additional brominated flame retarding agents may also be included in the composition. | 06-30-2011 |
Rachel Smith, Sherman Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20120039857 | SYSTEMS AND METHODS FOR CARDIAC TISSUE REPAIR - The present application relates to cardiac stem cells and a method of using cardiac stem cells to repair damaged heart tissue. In one embodiment, cardiac stem cells, such as cardiosphere-derived cells and/or cardiospheres, can be seeded, embedded and/or cultured in a biomaterial or matrix made from, for example, a hydrogel, that is subsequently administered to a subject to repair damaged heart tissue. | 02-16-2012 |
Rachel Soloff Nugent, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20110144312 | INTERLEUKIN 10 RECEPTOR (IL-10R) ANTIBODIES AND METHODS OF USE - The invention relates to IL-1O Receptor alpha (IL-1ORα) antibodies and subsequences thereof, human and humanized IL-10 Receptor alpha (IL-IORα) antibodies and subsequences thereof, isolated and purified IL-10 Receptor alpha (IL-1ORα) antibodies and subsequences thereof, compositions including IL-10 Receptor alpha (IL-1ORα) antibodies and subsequences thereof, and methods that employ IL-10 Receptor alpha (IL-1ORα) antibodies and subsequences thereof. The invention includes among other things, methods of treating a pathogen infection, pathogen reactivation, and methods of vaccinating or immunizing against a pathogen infection, which include, for example, administering an IL-10 Receptor alpha (IL-1ORα) antibody or subsequence, to treat a pathogen infection, pathogen reactivation or for vaccination or immunization. | 06-16-2011 |
Rachel Stengone, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090099178 | INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF - This invention is directed to Indazole Compounds or pharmaceutically acceptable salts, solvates and hydrates thereof. The Indazole Compounds have utility in the treatment or prevention of a wide range of diseases and disorders that are responsive to the inhibition, modulation or regulation of kinases, such as inflammatory diseases, abnormal angiogenesis and diseases related thereto, cancer, atherosclerosis, a cardiovascular disease, a renal disease, an autoimmune condition, macular degeneration, disease-related wasting, an asbestos-related condition, pulmonary hypertension, diabetes, obesity, pain and others. Thus, methods of treating or preventing such diseases and disorders are also disclosed, as are pharmaceutical compositions comprising one or more of the Indazole Compounds. This invention is based, in part, upon the discovery of a novel class of 5-triazolyl substituted indazole molecules that have potent activity with respect to the modulation of protein kinases. Thus, the invention encompasses orally active molecules as well as parenterally active molecules which can be used at lower doses or serum concentrations for treating diseases or disorders associated with protein kinase signal transduction. | 04-16-2009 |
Rachel Tkacz, Misgav IL
Patent application number | Description | Published |
---|---|---|
20100011983 | CLINGING ANCHOR FOR ACCESS GAINING - A launchable package for establishing anchorage in inaccessible locations. The launchable package contains a clinging component capable of attaching to a target; and a line for connection to the clinging component. Clinging can be achieved by a penetrating nail or by glue. The launchable package can be launched manually or by a launcher. | 01-21-2010 |
Rachel Toroni, Auburn, WA US
Patent application number | Description | Published |
---|---|---|
20120059021 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND METHODS FOR PREDICTING A RESPONSE TO SUCH TREATMENTS - The present disclosure relates to the regulation and function of the Wnt/β-catenin signaling pathway and the ERK signaling pathway. The disclosure provides methods of treatment for melanoma by administering both an inhibitor of ERK signaling and an activator of Wnt/β-catenin signaling. These methods may be used alone or in combination with other strategies targeting melanoma cell survival. The disclosure also provides diagnostic methods for predicting a patient's clinical response to inhibitors of ERK signaling. | 03-08-2012 |
Rachel Tzoref, Haifa IL
Patent application number | Description | Published |
---|---|---|
20090113399 | Device, System and Method of Debugging Computer Programs - Device, system, and method of debugging computer programs. For example, a method for debugging computer programs includes: locating a bug in a computer program based on a first score corresponding to a first instrumentation location of the computer program and a second score corresponding to a second instrumentation location of the computer program. | 04-30-2009 |
20090276379 | Using automatically generated decision trees to assist in the process of design and review documentation - An embodiment of this invention is to use automatically generated decision trees to assist in the design and review process. In one embodiment, the decision trees are automatically extracted from data describing a system (in case of design process) or a review artifact (in case of review process). In a further embodiment, the decision trees are then used in the design process, and the order of attributes in the decision tree suggests a new order for writing the design document. | 11-05-2009 |
20100046375 | Congestion Control Using Application Slowdown - A computer-implemented method is provided, including monitoring one or more parameters of a computer system that executes one or more service requester processes that issue service requests to one or more service provider processes. A congestion in the system is detected by analyzing the parameters. Upon identifying at least one of the service requester processes as contributing to the congestion, execution of the at least one of the service requester processes is slowed. Other embodiments are also described. | 02-25-2010 |
20100050161 | Detecting Locking Discipline Violations on Shared Resources - Detecting locking discipline violations on shared resources. For example, a method of detecting locking discipline violations of shared resources of a computing platform, by a testing process to be executed concurrently with one or more other processes on said computing platform, the testing process comprising: locking a shared resource of said computing platform; reading a value of the shared resource; locally storing the value of the shared resource; rereading the value of the shared resource after a predefined time period; and generating a locking discipline violation report if the value of said shared resource as reread by said rereading is different from the value of said resource as locally stored by said locally storing. | 02-25-2010 |
20100057965 | Extension of Lock Discipline Violation Detection for Lock Wait Patterns - A computer usable medium including computer usable program code for detection of potential shared memory access deadlocks. The code determines, when a process waits on a first shared memory access lock, if the process holds locks other than the first lock. If so, then the code issues a warning about potential deadlock. | 03-04-2010 |
20100324881 | SATISFIABILITY (SAT) BASED BOUNDED MODEL CHECKERS - A method uses a SAT solver operating to cycle k to find bugs in a model having finite computation paths therein, wherein said bugs are on computation paths of less than length k. Another method includes adding an additional state variable to a model to be checked, where a governing state machine of the additional variable has a “sink” state. The method includes having a translation using the additional variable whenever a state indicates a bad state and performing satisfiability solving with the model and the translation. | 12-23-2010 |
20110126173 | VERIFYING SYNCHRONIZATION COVERAGE IN LOGIC CODE - A computer implemented system and method for measuring synchronization coverage for one or more concurrently executed threads is provided. The method comprises updating an identifier of a first thread to comprise an operation identifier associated with a first operation, in response to determining that the first thread has performed the first operation; associating the identifier of the first thread with one or more resources accessed by the first thread; and generating a synchronization coverage model by generating a relational data structure of said one or more resources, wherein a resource is associated with at least the identifier of the first thread and an identifier of a second thread identifier, such that the second thread waits for the first thread before accessing said resource. | 05-26-2011 |
20110213605 | Satisfiability (SAT) Based Bounded Model Checkers - Systems and methods that use a solver to find bugs in a target model of a computing system having one or more finite computation paths are provided. The bugs on computation paths of less than a predetermined length are detected by translating the target model to include a state variable AF for one or more states of the target model, wherein AF(S) represents value of the state variable AF at state S; and solving the translated version of the target model that satisfies predetermined constrains. | 09-01-2011 |
20110252408 | PERFORMANCE OPTIMIZATION BASED ON DATA ACCESSES DURING CRITICAL SECTIONS - Detecting optimization opportunities is enabled by utilizing a trace of a target concurrent computer program and determining a relation between data objects accessed during the tracked execution. The relation may be stored in a Temporal Relation Graph (TRG), in an extended-TRG or another data structure. The relation may be affected by temporally-adjacent accesses to data objects. The relation may further be affected by accesses to data objects performed during critical sections of the target program. | 10-13-2011 |
20130014087 | SYNCHRONIZATION COVERAGE IN LOGIC CODE - A method for enhancing synchronization coverage for a logic code is provided. The method comprises tracking whether one or more code sections in the logic code are blocked by at least another code section in the logic code, or whether one or more code sections in the logic code are blocking at least another code section in the logic code, during one or more test runs; and including one or more delay mechanisms in the logic code to introduce a delay in execution of a first code section in the logic code, wherein length of introduced delay is dependent on whether the first code section was blocked by a second code section or whether the first code section was blocking the second code section. | 01-10-2013 |
20130247062 | VERIFYING SYNCHRONIZATION COVERAGE IN LOGIC CODE - A computer implemented system and method for measuring synchronization coverage for one or more concurrently executed threads is provided. The method comprises updating an identifier of a first thread to comprise an operation identifier associated with a first operation, in response to determining that the first thread has performed the first operation; associating the identifier of the first thread with one or more resources accessed by the first thread; and generating a synchronization coverage model by generating a relational data structure of said one or more resources, wherein a resource is associated with at least the identifier of the first thread and an identifier of a second thread identifier, such that the second thread waits for the first thread before accessing said resource. | 09-19-2013 |
Rachel Tzoref-Brill, Haifa IL
Patent application number | Description | Published |
---|---|---|
20120233596 | MEASURING COUPLING BETWEEN COVERAGE TASKS AND USE THEREOF - Test coverage is enhanced by measuring various types of coupling between coverage tasks. The coupling measurements may be implicit coupling measurements, explicit coupling measurements, coding coupling measurements, performance coupling measurements, resource coupling measurements or the like. Coupling scores are calculated for coverage tasks and based thereon ranking of the coverage tasks or groups of coverage tasks may be determined The ranking may be utilized in selecting for which uncovered coverage task a test should be designed. The ranking may be utilized in computing a coverage measurement of a test suite. The ranking may be utilized to rank tests, based on the coverage tasks each test covers. Ranking of tests may be utilized for various purposes such as performing test selection. | 09-13-2012 |
20120233614 | MEASURING COUPLING BETWEEN COVERAGE TASKS AND USE THEREOF - Test coverage is enhanced by measuring various types of coupling between coverage tasks. The coupling measurements may be implicit coupling measurements, explicit coupling measurements, coding coupling measurements, performance coupling measurements, resource coupling measurements or the like. Based on the coupling measurements, different coverage tasks may be grouped together. For example, closely coupled coverage tasks may be grouped together. The groups may also be determined based on an initial distribution of groups, by combining groups having closely coupled member coverage tasks. The groups may be ordered and prioritized, such as based on the size of the groups and the number of uncovered tasks in each group. The groups may also be ordered, such as based on coupling score which aggregate the coupling measurements of the member coverage tasks. | 09-13-2012 |
20120260132 | TEST SELECTION BASED ON AN N-WISE COMBINATIONS COVERAGE - Based on a functional coverage by a test suite, a functional coverage model of a System Under Test (SUT) may be defined to represent all covered combinations of functional attributes. Based on an n-wise combination criteria, a subset of the possible combinations of values may be determined A subset of the test suite may be selected such that the selected subset is operative to cover the subset of the determined possible combinations of values. The disclosed subject matter may be used to reduce a size of the test suite while preserving the n-wise combinations coverage of the original test suite. | 10-11-2012 |
20120324286 | UTILIZING AUXILIARY VARIABLES IN MODELING TEST SPACE FOR SYSTEM BEHAVIOR - Systems and methods for modeling test space for verifying system behavior, using one or more auxiliary variables, are provided. The method comprises implementing a functional coverage model including: one or more attributes, wherein respective values for the attributes are assigned according to a test plan, and one or more constraints defining restrictions on value combinations assigned to the attributes, wherein the restrictions are Boolean expressions defining whether said value combinations are valid; determining a set of valid value combinations for the attributes that satisfy the restrictions to define the test space for verifying the system behavior; and determining relevant auxiliary variables and a corresponding function for said auxiliary variables to reduce the complexity associated with modeling the test space. | 12-20-2012 |
20120324414 | BDD-BASED FUNCTIONAL MODELING - A computer-implemented method, apparatus, and computer program product for assisting in dynamic verification of a System Under Test (SUT). The method comprising obtaining a set of functional attributes and associated domains with respect to a System Under Test (SUT), and obtaining a set of restrictions over the functional attributes and associated domains. The method comprising encoding a Binary Decision Diagram (BDD) to represent a Cartesian cross-product test-space of all possible combinations of values of the functional attributes excluding combinations that are restricted by the set of restrictions, whereby the BDD symbolically represents the Cartesian cross-product test-space. The method may further comprise analyzing the Cartesian cross-product test-space by manipulating the BDD so as to assist in performing dynamic verification of the SUT. | 12-20-2012 |
20130085741 | Test Planning Based on Dynamic Coverage Analysis - A method for refining a test plan is provided. The method comprises defining a coverage model including: one or more variables, wherein respective values for the variables are assigned, and one or more definitions for value combinations for said variables with assigned values, wherein zero or more of said value combinations are defined according to one or more restrictions for the purpose of generating a test plan to test a system for which the coverage model is constructed; determining zero or more uncovered value combinations in the test plan; and providing means to update the test plan. | 04-04-2013 |
20130090911 | Modeling Test Space for System Behavior Using Interchangeable Designations - A method for modeling test space for verifying system behavior is provided. The method comprises defining a coverage model based on one or more variables, wherein respective value combinations for the variables are assigned to define a test space for a system under test, and zero or more constraints define restrictions on value combinations assigned to the variables, wherein the restrictions define whether said value combinations are valid; and designating, as interchangeable, relevant variables values in the coverage model. | 04-11-2013 |
20130091382 | Modeling Test Space for System behavior with Optional Variable combinations - A method for modeling a test space is provided. The method comprises defining a coverage model including: one or more variables, wherein respective values for the variables are assigned, and one or more definitions for value combinations for said variables with assigned values, wherein at least one of said value combinations is defined as optional, and zero or more other said value combinations are defined as forbidden or mandatory for purpose of generating test scenarios to test a system for which the coverage model is defined. | 04-11-2013 |
20130103983 | BDD-BASED FUNCTIONAL COVERAGE ANALYSIS - Obtaining a functional coverage model of a System Under Test (SUT) defining all functional coverage tasks of the SUT, wherein the functional coverage model defining a test-space with respect to functional attributes; obtaining a set of covered functional coverage tasks; encoding a covered Binary Decision Diagram (BDD) to represent the set of covered functional coverage tasks within the test-space; and manipulating the covered BDD to identify one or more coverage holes, wherein a coverage hole defines a set of coverage tasks in the test-space, all having a same combination of values to a subset of the functional attributes, that are not covered by the set of covered functional coverage task. | 04-25-2013 |
20130110489 | AUTOMATIC DESIGNATION OF EQUIVALENT VARIAVLE VALUES | 05-02-2013 |
20130239094 | DETECTING LOCKING DISCIPLINE VIOLATIONS ON SHARED RESOURCES - Detecting locking discipline violations on shared resources. For example, a method of detecting locking discipline violations of shared resources of a computing platform, by a testing process to be executed concurrently with one or more other processes on said computing platform, the testing process comprising: locking a shared resource of said computing platform; reading a value of the shared resource; locally storing the value of the shared resource; rereading the value of the shared resource after a predefined time period; and generating a locking discipline violation report if the value of said shared resource as reread by said rereading is different from the value of said resource as locally stored by said locally storing. | 09-12-2013 |
20130262017 | METHOD AND APPARATUS FOR REUSING PARTS OF EXISTING TESTS - An apparatus, computer-implemented method performed by a computerized device and a computer program product, the method comprising: receiving an attribute collection related to a domain, the attribute collection comprising two or more attributes; receiving one or more restrictions, each restriction indicating one or more attributes, wherein a value for the attribute is to be selected from one existing test; receiving an existing test; and generating one or more new tests by setting values for the two or more attributes, wherein values for the one or more attributes of the one or more restrictions are selected from the existing test, and one or more values for one or more other attributes are not selected from the existing test. | 10-03-2013 |
20140012560 | Completion of Partial Coverage Tasks - A method, apparatus and product for completion of partial coverage tasks. The method comprising obtaining a partial coverage task defining a test with respect to a functional coverage model of a System Under Test (SUT), wherein the functional coverage model defining functional attributes and respective domains thereof, wherein the functional coverage model further defining one or more restrictions on value combinations of the functional attributes; and enhancing the partial coverage task to include an assignment of a value to a functional attribute, wherein the functional attribute is unassigned in the partial coverage task, wherein the value is an only valid assignment to the functional attribute in view of assignments of other functional attributes and in view of the restrictions. | 01-09-2014 |
20140059081 | Attribute Value Properties for Test Selection with Cartesian Product Models - A method for modeling a test space is provided. The method comprises defining a coverage model including one or more attributes, wherein respective values for the attributes are assigned, one or more definitions of value properties for said attributes with assigned values, and one or more requirements that limit combination of attribute values that are legal for the model, wherein at least one of said requirements is defined using at least one value property. | 02-27-2014 |
20140137057 | Test Validation Planning - A computer-implemented method, computerized apparatus, and computer program product for test validation planning. The computer-implemented method, performed by a processor, comprising: having a test validation activity to be performed to validate results of two or more tests of a test suite; and automatically determining, by a processor, a subset of the two or more tests for which to perform the test validation activity; whereby avoiding performing duplicate validation activities. Optionally, for each test of the test suite a valuation of a set of functional attributes is available, and a subset of the functional attributes is deemed as relevant functional attributes with respect to the test validation activity. In such an embodiment, said determining is based on the valuation of the relevant functional attributes. | 05-15-2014 |
20140317450 | PRETEST SETUP PLANNING - A computer-implemented method comprising: obtaining a description of a test suite which comprises a plurality of tests, wherein each test of the test suite is described by values of functional attributes, wherein at least a portion of the functional attributes are setup-related attributes, wherein a combination of values of the setup-relates attributes potentially indicate a setup activity to be performed prior to executing the test to set up a test environment for the test. Identifying, based on the description of the test suite, a setup activity that is associated with two or more tests, wherein the setup activity is configured to set up a component of the test environment, wherein the identifying is performed by a processor. Providing a first instruction to perform the setup activity prior to executing a first test of the two or more tests. And, providing a second instruction to reuse the component of the test environment when executing additional tests of the two or more tests, whereby avoiding performing duplicate setup activities. | 10-23-2014 |
20140372083 | DERIVED RESTRICTIONS IN A COMBINATORIAL MODEL - A method, apparatus and product for determining a derived restriction in a combinatorial model. The method comprising: obtaining a combinatorial model defining a test space, the combinatorial model comprising a set of attributes, a respective domain for each attribute, and a set of restrictions, wherein the restrictions define a combination of values of the attributes that are restricted from the test space; and automatically determining a derived restriction that is derived from at least a first restriction and a second restriction, the first and second restrictions are comprised by the set of restrictions, wherein the derived restriction restricts at least one combination of values that is not restricted by the first restriction and at least one combination of values that is not restricted by the second restriction. | 12-18-2014 |
Rachel Vanwinkle, Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20100070904 | Interactive Tree Plot for Flow Cytometry Data - Methods, systems, and computer program products can be used for displaying and analyzing data. A method operates by receiving and displaying flow cytometry data in a tree plot, which represents multiple variations of classified flow cytometry data within an interface of computer that includes an input device. The interface permits a user to select, using the input device, portions of the tree plot associated with characteristics and sub-sets of the data. In an example, one or more histograms, contour plots, density plots, radar plots, and scatter plots representing the data are displayed within the interface. The interface permits a user to select, using the input device, portions of the histograms, contour plots, density plots, radar plots, and scatter plots, corresponding to characteristics and sub-sets of the data. In an example, updated histograms and plots are displayed in the interface substantially immediately based upon selected characteristics and subsets of the data. | 03-18-2010 |
Rachel Wang, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080287155 | MULTIPLEXING AND POWER CONTROL OF UPLINK CONTROL CHANNELS IN A WIRELESS COMMUNICATION SYSTEM - Techniques for transmitting control information in a wireless communication system are described. The system may support acknowledgement (ACK) channels and channel quality indicator (CQI) channels, which may have different target signal-to-noise ratios (SNRs). The ACK and CQI channels from different user equipments (UEs) may be multiplexed on the same resource block. In one design, the transmit power of a CQI channel may be set to achieve a nominal target SNR for CQI when not multiplexed with the ACK channels and may be reduced to achieve a lower target SNR when multiplexed with the ACK channels. In another design, the transmit power of an ACK channel may be set to achieve a nominal target SNR for ACK when not multiplexed with the CQI channels and may be boosted to achieve a higher target SNR when multiplexed with the CQI channels. The CQI channel may randomly hop to mitigate performance degradation. | 11-20-2008 |
20080298502 | PILOT STRUCTURES FOR ACK AND CQI IN A WIRELESS COMMUNICATION SYSTEM - Techniques for transmitting data and pilot for control information are described. In one aspect, a user equipment (UE) may spread a reference signal sequence with a first orthogonal sequence to obtain multiple pilot sequences. The UE may then send the multiple pilot sequences on multiple subcarriers in multiple symbol periods, one pilot sequence in each symbol period. The UE may modulate the reference signal sequence with control information (e.g., ACK information) to obtain a modulated sequence. The UE may spread the modulated sequence with a second orthogonal sequence to obtain multiple data sequences. The UE may then send the multiple data sequences on the multiple subcarrier in multiple symbol periods for data. In another aspect, the UE may send multiple pilot sequences on multiple subcarriers in multiple symbol periods separated by at least one symbol period, one pilot sequence in each symbol period. | 12-04-2008 |
20140307675 | PILOT STRUCTURES FOR ACK AND CQI IN A WIRELESS COMMUNICATION SYSTEM - Techniques for transmitting data and pilot for control information are described. In one aspect, a user equipment (UE) may spread a reference signal sequence with a first orthogonal sequence to obtain multiple pilot sequences. The UE may then send the multiple pilot sequences on multiple subcarriers in multiple symbol periods, one pilot sequence in each symbol period. The UE may modulate the reference signal sequence with control information (e.g., ACK information) to obtain a modulated sequence. The UE may spread the modulated sequence with a second orthogonal sequence to obtain multiple data sequences. The UE may then send the multiple data sequences on the multiple subcarriers in multiple symbol periods for data. In another aspect, the UE may send multiple pilot sequences on multiple subcarriers in multiple symbol periods separated by at least one symbol period, one pilot sequence in each symbol period. | 10-16-2014 |
Rachel Watson-Clark, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20110229516 | ADJUVANT PHASE INVERSION CONCENTRATED NANOEMULSION COMPOSITIONS - Vaccine adjuvant food nanoemulsion compositions comprising a food safe nonionic surfactant, a hydrophobic food flavorant (e.g., an essential oil), a kosmotrope, and water. The nanoemulsion composition can be used as a vaccine adjuvant composition to enhance inactivated antigens, including protein antigens. Such compositions may be delivered as a nasal or oral spray. The compositions may inherently contain natural antimicrobials and antioxidants and are advantageous over other compositions which often require preservatives, flavorings and antimicrobials. | 09-22-2011 |
20140127379 | SHELF-STABLE TEXTURED SANDWICH SPREADS - Textured sandwich spread or dip compositions comprising a dairy component comprising cream cheese, an oil-water emulsion comprising oil and water, and a legume-based component. The combination of cream cheese and the legume-based component provide a significantly more hearty texture to the composition than that provided by existing sandwich spreads, such as mayonnaise or mustard. The composition is advantageously phase stable so as to provide excellent shelf-stability so that proteins and other solid components of the composition do not retrograde or precipitate, even when hot filled into a container during preparation and packaging. | 05-08-2014 |
Rachel Wezeman, Middleton, WI US
Patent application number | Description | Published |
---|---|---|
20100305182 | COMPOUNDS AND METHODS FOR MODULATING COMMUNICATION AND VIRULENCE IN QUORUM SENSING BACTERIA - The present invention provides compositions and methods for modulating the communication and virulence of quorum sensing bacteria. In various exemplary embodiments, the invention provides a combinatorial library of quorum sensing compounds including synthetic analogs of naturally occurring and non-naturally occurring acyl-homoserine lactone (AHL) analogs, and methods of synthesizing and using these compounds. | 12-02-2010 |
Rachel Yerushalmi-Rozen, Kfar Varburg IL
Patent application number | Description | Published |
---|---|---|
20080255294 | Method For the Preparation of Dispersions of Carbon Nanotubes - The invention provides a method for the preparation of a suspension of de-agglomerated carbon nanotubes, comprising mixing agglomerated carbon nanotubes with a block copolymer. Further, a powder of de-agglomerated carbon nanotubes is provided, that can be easily redispersed to obtain a suspension of untangled carbon nanotubes. The invention also relates to the use of the provided materials in the preparation of composites, and in electronics. | 10-16-2008 |
Rachel Zamostiano, Hod-Hasharon IL
Patent application number | Description | Published |
---|---|---|
20090124543 | ACTIVITY DEPENDENT NEUROTROPHIC FACTOR III (ADNF III) - The present invention relates generally to Activity Dependent Neurotrophic Factor III (ADNF III), also known as Activity Dependent Neuroprotective Protein (ADNP). More particularly, the present invention relates to nucleic acid sequences encoding ADNF III polypeptides; ADNF III polypeptides encoded by such nucleic acid sequences; antibodies to ADNF III polypeptides; and methods of using such ADNF III polypeptides for the treatment of neurological deficiencies and for the prevention of cell death associated with (1) gp120, the envelope protein from HIV; (2) N-methyl-D-aspartic acid (excito-toxicity); (3) tetrodotoxin (blockage of electrical activity); and (4) β-amyloid peptide, a substance related to neuronal degeneration in Alzheimer's disease. | 05-14-2009 |
Rachel Zlobinsky, Kiryat Ono IL
Patent application number | Description | Published |
---|---|---|
20110034302 | SYSTEM AND METHOD FOR SUPERVISED HOME CARE REHABILITATION OF STROKE SURVIVORS - A transportable apparatus for performing cardiovascular training, including: an exercise device that is adapted to enable a user to perform a specific motion pattern; an ergometer that provides an indication of the amount of work performed by the user of the exercise device; an alarm system that provides an indication to the user responsive to the readings of the ergometer; wherein the alarm system is preprogrammed to provide indications responsive to one or more readings of the ergometer based on the results of a cardiorespiratory exercise test performed on the user with the exercise device. | 02-10-2011 |
Rachel Zlobinsky, Kiryat Tivon IL
Patent application number | Description | Published |
---|---|---|
20120129655 | SYSTEM AND METHOD FOR SUPERVISED HOME CARE REHABILITATION OF STROKE SURVIVORS - A transportable apparatus for performing cardiovascular training, including: an exercise device that is adapted to enable a user to perform a specific motion pattern; an ergometer that provides an indication of the amount of work performed by the user of the exercise device; an alarm system that provides an indication to the user responsive to the readings of the ergometer; wherein the alarm system is preprogrammed to provide indications responsive to one or more readings of the ergometer based on the results of a cardiorespiratory exercise test performed on the user with the exercise device. | 05-24-2012 |